What is MURA's current stock price?

MURA (Mural Oncology plc) is currently trading at $2.04 with a market cap of $35.4M.

What sector is Mural Oncology plc in?

Mural Oncology plc (MURA) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

MURA Mural Oncology plc

NASDAQHealthcare

$2.04+0.00%ClosedMarket Cap: $35.4M

As of 2025-12-09 09:30

Why MURA matters now

Mural Oncology plc (MURA) is a US stock in Healthcare. The latest InvestLog snapshot shows $2.04 with +0.00% on the session and $35.4M in market capitalization.

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

2.96

Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.